AbbVie Inc. DEF 14A: Executive Compensation Details
Ticker: ABBV · Form: DEF 14A · Filed: Mar 24, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | DEF 14A |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, annual-meeting, corporate-governance, sec-filing
Related Tickers: ABBV
TL;DR
AbbVie's 2025 DEF 14A drops: exec pay details for 2024, board grants on Feb 15.
AI Summary
AbbVie Inc. filed a DEF 14A with the SEC on March 24, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and board member information, including compensation for members like Michael Member and Gonzalez Member for the period of January 1, 2024, to December 31, 2024. It also lists grants and awards made on February 15, 2024, to individuals such as Timothy J. Richmond and Scott T. Reents.
Why It Matters
This filing provides transparency into how AbbVie Inc. compensates its top executives and board members, which can influence investor decisions and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) detailing executive compensation and board information, with no immediate indication of significant new risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the compensation details in this filing.)
- 20250324 — Filing Date (The date AbbVie Inc. submitted this DEF 14A to the SEC.)
- 2024-01-01 — Compensation Period Start (Beginning of the period for which executive compensation is detailed.)
- 2024-02-15 — Award Date (Date when specific grants and awards were made to individuals.)
Key Players & Entities
- AbbVie Inc. (company) — Filer of the DEF 14A
- Michael Member (person) — Executive/Board Member mentioned in compensation details
- Gonzalez Member (person) — Executive/Board Member mentioned in compensation details
- Timothy J. Richmond (person) — Recipient of awards on February 15, 2024
- Scott T. Reents (person) — Recipient of awards on February 15, 2024
- Jeffrey R. Stewart (person) — Recipient of awards on February 15, 2024
- Azita Saleki Gerhardt (person) — Recipient of awards on February 15, 2024
FAQ
What is the primary purpose of this DEF 14A filing by AbbVie Inc.?
The primary purpose of this DEF 14A filing is to provide information regarding the solicitation of proxies for the company's annual meeting of stockholders, including details on executive compensation, board of directors, and other corporate governance matters.
Who are some of the individuals mentioned in relation to compensation or awards in the filing?
The filing mentions individuals such as Michael Member, Gonzalez Member, Timothy J. Richmond, Scott T. Reents, Jeffrey R. Stewart, and Azita Saleki Gerhardt in the context of compensation and awards for the 2024 fiscal year.
What is the reporting period for the compensation information provided?
The compensation information provided in this filing primarily covers the fiscal year from January 1, 2024, to December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on March 24, 2025.
What specific date were awards or grants made to certain individuals?
Awards and grants were made on February 15, 2024, to individuals including Timothy J. Richmond, Scott T. Reents, Michael Member, Jeffrey R. Stewart, Gonzalez Member, and Azita Saleki Gerhardt.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 24, 2025 by Michael Member regarding AbbVie Inc. (ABBV).